Skip to main content

Methotrexate: CBC within 12 weeks

CBE ID
0598
1.4 Project
Musculoskeletal Endorsement Maintenance
Endorsed
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
E&M Cycle
Spring 2014
Is Under Review
No
1.3 Measure Description

This measure identifies adult patients with rheumatoid arthritis who were prescribed at least a 6-month supply of methotrexate during the measurement year and received a CBC test within 120 days (3 months + 1 month grace period) following the earliest observed methotrexate prescription claim

    • 1.14 Numerator

      Patients in the denominator who received a CBC test within 120 days following the earliest observed methotrexate prescription claim

      Time Window: See below

    • 1.15 Denominator

      Patients >=18 years old with rheumatoid arthritis who have received at least a 6-month supply of oral methotrexate during the measurement year

      Time Window: See below

    • Exclusions

      Exclude members with an inpatient hospitalization during the 120 days after the earliest observed methotrexate prescription

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Musculoskeletal Endorsement Maintenance Project
      Initial Endorsement
      Last Updated
      Removal Date